Literature DB >> 30992598

Vaccine usage in western Canadian cow-calf herds.

Cheryl L Waldner1, Sarah Parker1, John R Campbell1.   

Abstract

The aims of this study were to describe when and how vaccines are administered during the production cycle in cow-calf herds in western Canada, as well as the factors that influence vaccine usage as reported by producers. The most commonly used vaccines were bovine viral diarrhea virus/infectious bovine rhinotracheitis (BVDV/IBR) in adult animals and clostridial vaccines in calves. While there has been improvement in usage of reproductive and respiratory viral vaccines since previous studies, there are still several areas in which uptake could be improved. Only 72% of herd owners vaccinated their bulls for at least 1 disease. Not all producers are vaccinating their calves for clostridial diseases, and 15% of producers did not vaccinate their calves for respiratory disease before weaning. One goal of increasing vaccine use is to obtain better infection prevention and control and decrease antimicrobial use in cow-calf herds. Two areas in which antimicrobials are commonly used, but vaccine uptake is limited, are foot rot in adult cows and diarrhea in calves.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30992598      PMCID: PMC6417607     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  18 in total

1.  Persistent bovine pestivirus infection localized in the testes of an immuno-competent, non-viraemic bull.

Authors:  H Voges; G W Horner; S Rowe; G J Wellenberg
Journal:  Vet Microbiol       Date:  1998-03-31       Impact factor: 3.293

Review 2.  Evidence-based effectiveness of vaccination against Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in feedlot cattle for mitigating the incidence and effect of bovine respiratory disease complex.

Authors:  R L Larson; D L Step
Journal:  Vet Clin North Am Food Anim Pract       Date:  2012-03       Impact factor: 3.357

Review 3.  Evidence-based medicine concerning efficacy of vaccination against Clostridium chauvoei infection in cattle.

Authors:  Francisco A Uzal
Journal:  Vet Clin North Am Food Anim Pract       Date:  2012-01-29       Impact factor: 3.357

4.  Effects of bovine herpesvirus type 1 infection in calves with maternal antibodies on immune response and virus latency.

Authors:  M Lemaire; V Weynants; J Godfroid; F Schynts; G Meyer; J J Letesson; E Thiry
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

5.  Efficacy of bovine viral diarrhea virus vaccination to prevent reproductive disease: a meta-analysis.

Authors:  Benjamin W Newcomer; Paul H Walz; M Daniel Givens; Alan E Wilson
Journal:  Theriogenology       Date:  2014-10-02       Impact factor: 2.740

Review 6.  Bovine herpesvirus 1 modified live virus vaccines for cattle reproduction: Balancing protection with undesired effects.

Authors:  Christopher C L Chase; Robert W Fulton; Donal O'Toole; Benjamin Gillette; Russell F Daly; George Perry; Travis Clement
Journal:  Vet Microbiol       Date:  2017-03-23       Impact factor: 3.293

7.  Systematic review and meta-analysis of the effectiveness of commercially available vaccines against bovine herpesvirus, bovine viral diarrhea virus, bovine respiratory syncytial virus, and parainfluenza type 3 virus for mitigation of bovine respiratory disease complex in cattle.

Authors:  Miles E Theurer; Robert L Larson; Brad J White
Journal:  J Am Vet Med Assoc       Date:  2015-01-01       Impact factor: 1.936

8.  Cow attributes, herd management, and reproductive history events associated with the risk of nonpregnancy in cow-calf herds in Western Canada.

Authors:  C L Waldner; A García Guerra
Journal:  Theriogenology       Date:  2013-03-06       Impact factor: 2.740

9.  Effect of calf age and administration route of initial multivalent modified-live virus vaccine on humoral and cell-mediated immune responses following subsequent administration of a booster vaccination at weaning in beef calves.

Authors:  Amelia R Woolums; Roy D Berghaus; Londa J Berghaus; Roger W Ellis; Mel E Pence; Jeremiah T Saliki; Katherine A E Hurley; Kimberly L Galland; William W Burdett; Scott T Nordstrom; David J Hurley
Journal:  Am J Vet Res       Date:  2013-02       Impact factor: 1.156

Review 10.  Assessment of methodological quality and sources of variation in the magnitude of vaccine efficacy: a systematic review of studies from 1960 to 2005 reporting immunization with Moraxella bovis vaccines in young cattle.

Authors:  M J Burns; A M O'Connor
Journal:  Vaccine       Date:  2007-10-26       Impact factor: 3.641

View more
  5 in total

1.  A field comparison of heterologous and homologous routes of administration of modified live vaccines for the control of bovine respiratory disease in recently weaned beef calves.

Authors:  Nathan Erickson; John Ellis; Cheryl Waldner; Herbert Lardner; Sheryl Gow; John Campbell; Adam Berenik
Journal:  Can Vet J       Date:  2020-05       Impact factor: 1.008

2.  Evaluation of bovine respiratory syncytial virus (BRSV) and bovine herpesvirus (BHV) specific antibody responses between heterologous and homologous prime-boost vaccinated western Canadian beef calves.

Authors:  Nathan E N Erickson; Adam Berenik; Herbert Lardner; Stacey Lacoste; John Campbell; Sheryl Gow; Cheryl Waldner; John Ellis
Journal:  Can Vet J       Date:  2021-01       Impact factor: 1.008

3.  Blackleg in Cattle in the Irkutsk Region.

Authors:  Andrei A Blokhin; Nadezhda N Toropova; Olga A Burova; Ivan V Iashin; Olga I Zakharova
Journal:  Front Vet Sci       Date:  2022-05-12

4.  Comparison of bovine viral diarrhea virus-specific antibody responses of young beef calves vaccinated with either modified live virus or inactivated virus regimens.

Authors:  Nathan Erickson; John Ellis; Cheryl Waldner; Herbert Lardner; Sheryl Gow; John Campbell; Adam Berenik
Journal:  Can Vet J       Date:  2020-08       Impact factor: 1.008

5.  Biosecurity practices in western Canadian cow-calf herds and their association with animal health.

Authors:  Trent R Wennekamp; Cheryl L Waldner; Sarah Parker; M Claire Windeyer; Kathy Larson; John R Campbell
Journal:  Can Vet J       Date:  2021-07       Impact factor: 1.008

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.